纳米技术在解决氧化应激相关肝脏疾病方面的影响越来越大
Sathiyamoorthy Padmanaban1, Durgasruthi Pully2, Antony V Samrot3
1Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
Antioxidants (Basel, Switzerland)
|July 29, 2023
概括
反应性氧物种 (ROS) 在肝脏疾病中至关重要. 纳米技术提供了有前途的纳米抗氧化剂来对抗氧化应激,并改善酒精和非酒精性脂肪肝炎等疾病的治疗方法.
科学领域:
- 生物化学 生化学
- 纳米医学是一种纳米医学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 活性氧物种 (ROS) 是生物系统的组成部分,影响着生存和衰退.
- 在脂肪肝炎等肝脏疾病中,ROS既起病因作用,又起后果作用.
- 酒精性脂肪肝炎 (ASH) 和非酒精性脂肪肝炎 (NASH) 是这种疾病的关键例子.
研究的目的:
- 探索在与氧化应激相关的肝脏疾病中准ROS形成的治疗潜力.
- 研究纳米技术在开发新型抗氧化剂策略中的作用.
- 为了强调外源抗氧化剂的必要性,当内源防御被压倒时.
主要方法:
- 对肝脏病理生理学中的ROS现有文献的综述.
- 对目前针对ROS的治疗策略的分析.
- 探索基于纳米技术的方法,特别是纳米抗氧化剂.
- 评估纳米复杂系统在向抗氧化剂输送方面的优势.
主要成果:
- 对针对肝脏疾病的ROS药物的兴趣日益增长.
- 哺乳动物系统拥有对ROS的内在抗氧化防御.
- 外源抗氧化剂随着肝脏状况的进展变得至关重要.
- 纳米技术提供高效的纳米抗氧化剂,改善了传递和准.
结论:
- 纳米技术为控制肝脏疾病中的ROS水平提供了一个有希望的策略.
- 纳米抗氧化剂通过有针对性的输送和减少泄漏提供了更高的有效性.
- 进一步探索纳米技术对于开发有效的治疗氧化应激相关肝脏疾病至关重要.
更多相关视频
03:35Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research
Published on: June 28, 2024
1.4K
08:16Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
8.8K
相关概念视频
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Phase I Oxidative Reactions: Overview
307
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
307
